SynthesisFrontiers in medicine2023

Prophylactic use of interleukin 6 monoclonal antibody can reduce CRS response of CAR-T cell therapy.

Baitao Dou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.